封面
市場調查報告書
商品編碼
1291481

醫藥精細化學品市場:2023-2028年全球行業趨勢、佔有率、規模、成長、機會和預測

Pharmaceutical Fine Chemicals Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

市場概況:

全球醫藥精細化學品市場規模在2022年達到1326億美元。展望未來,IMARC Group預計到2028年,市場規模將達到1953億美元,在2023-2028年期間表現出6.42%的成長率(CAGR)。

精細化學品是指一組以較高價格生產的有限數量的純淨和複雜化學品。它們是在多用途工廠中,在多步驟批量生物技術方法的支持下生產的。與特種化學品不同的是,這些物質是根據其獨特的功能特點和特定的分子特性精確積累的。在收集之後,精細化學品被用作生產一些醫藥化工產品的關鍵劑、穩定劑和溶劑,包括硬脂酸鎂和明膠。目前,它們在商業上有專利和非專利的變種。

醫藥精細化學品市場趨勢:

各種神經和心血管疾病,包括心律失常、中風、癌症和冠狀動脈疾病,特別是在老年人口中的發病率越來越高,這是推動醫藥精細化工市場發展的主要因素之一。與此相呼應,一些國家的政府機構為引進新型疫苗、藥物和醫藥藥物以抵禦冠狀病毒疾病(COVID-19)和其他一些疾病而採取的有利計劃,進一步促進了這些藥物在醫療保健領域的廣泛採用。這反過來又成為該市場的另一個成長誘導因素。此外,在滿足品質標準的前提下,利用醫藥精細化學品作為原料生產藥品的不同準則的實施,也促進了市場的成長。其他因素,如製藥業的顯著擴張,對研究和開發(R&D)活動的投資增加,以及消費者對眾多疾病和現有藥物選擇的認識不斷提高,都為全球市場創造了積極的前景。

本報告所回答的關鍵問題:

  • 迄今為止,全球醫藥精細化學品市場的表現如何,在未來幾年將如何表現?
  • COVID-19對全球醫藥精細化學品市場的影響是什麼?
  • 主要的區域市場是什麼?
  • 基於類型的市場細分是什麼?
  • 基於產品的市場細分是什麼?
  • 基於規模的市場細分是什麼?
  • 基於應用的市場細分是什麼?
  • 該行業價值鏈的各個階段是什麼?
  • 該行業的關鍵驅動因素和挑戰是什麼?
  • 全球醫藥精細化學品市場的結構是什麼,誰是主要的參與者?
  • 該行業的競爭程度如何?

目錄

第一章:前言

第二章:範圍和方法

  • 研究的目標
  • 利益相關者
  • 數據來源
    • 主要來源
    • 二級來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第三章:執行摘要

第四章:簡介

  • 概述
  • 主要行業趨勢

第五章:全球醫藥精細化學品市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第六章:按類型分類的市場

  • 專有的
    • 市場趨勢
    • 市場預測
  • 非專有的
    • 市場趨勢
    • 市場預測

第7章:按產品分類的市場

  • 有效成分
    • 市場趨勢
    • 市場預測
  • 基本構件
    • 市場趨勢
    • 市場預測
  • 高級中間體
    • 市場趨勢
    • 市場預測

第8章:按規模分類的市場

  • 大分子化合物
    • 市場趨勢
    • 市場預測
  • 小分子藥物
    • 市場趨勢
    • 市場預測

第九章:按應用分類的市場

  • 心血管疾病
    • 市場趨勢
    • 市場預測
  • 神經系統
    • 市場趨勢
    • 市場預測
  • 腫瘤學
    • 市場趨勢
    • 市場預測
  • 呼吸系統
    • 市場趨勢
    • 市場預測
  • 胃腸道
    • 市場趨勢
    • 市場預測
  • 肌肉骨骼類
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第十章:按地區分類的市場

  • 北美洲
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場預測
  • 亞太地區
    • 中國
      • 市場趨勢
      • 市場預測
    • 日本
      • 市場趨勢
      • 市場預測
    • 印度
      • 市場趨勢
      • 市場預測
    • 韓國
      • 市場趨勢
      • 市場預測
    • 澳大利亞
      • 市場趨勢
      • 市場預測
    • 印尼
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場預測
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 義大利
      • 市場趨勢
      • 市場預測
    • 西班牙
      • 市場趨勢
      • 市場預測
    • 俄羅斯
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢
      • 市場預測
    • 墨西哥
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 按國家分類的市場
    • 市場預測

第十一章:SWOT分析

  • 概述
  • 優勢
  • 劣勢
  • 機會
  • 威脅

第十二章:價值鏈分析

第十三章:波特斯五力分析

  • 概述
  • 買方的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第十四章:價格分析

第十五章:競爭格局

  • 市場結構
  • 主要參與者
  • 主要參與者的概況
    • BASF SE
    • Borregaard ASA
    • CHEMADA Industries Ltd. (Turpaz)
    • Denisco Chemicals Pvt Ltd
    • Dupont De Nemours Inc.
    • Eastman Chemical Company
    • Evonik Industries AG
    • Koninklijke DSM NV
    • Lonza Group AG
    • Solvay SA
    • Syntor Fine Chemicals Ltd. (Aceto Corporation)
    • WR Grace and Co. (Standard Industries Inc.)
Product Code: SR112023A5910

Market Overview:

The global pharmaceutical fine chemicals market size reached US$ 132.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 195.3 Billion by 2028, exhibiting a growth rate (CAGR) of 6.42% during 2023-2028.

Fine chemicals refer to a set of pure and complex chemicals that are manufactured in limited quantities at higher prices. They are produced in multipurpose plants with the support of a multistep batch biotechnological method. Unlike specialty chemicals, these substances are accumulated precisely based on their distinct functional characteristics and specific molecular properties. After collection, fine chemicals are used as key agents, stabilizers, and solvents for producing several pharmaceutical chemical products, including magnesium stearate and gelatin. At present, they are commercially available in proprietary and non-proprietary variants.

Pharmaceutical Fine Chemicals Market Trends:

The increasing prevalence of various neurological and cardiovascular diseases, including arrhythmias, stroke, cancer, and coronary artery ailments, especially amongst the geriatric population, is one of the prime factors driving the pharmaceutical fine chemical market toward growth. In line with this, favorable initiatives undertaken by the government bodies of several nations for introducing novel vaccines, drugs, and pharmaceutical medications for retaliating against coronavirus diseases (COVID-19) and several other disorders is further facilitating the widespread adoption of these medications in the healthcare sector. This, in turn, is acting as another growth-inducing factor in the market. Additionally, enforcement of different guidelines for utilizing pharmaceutical fine chemicals as raw materials to manufacture medicines, while meeting the quality standards is contributing to the market growth. Other factors, such as significant expansion in the pharmaceutical industry, increasing investments in the research and development (R&D) activities, and the growing consumer awareness regarding numerous disorders and the available medication options, are creating a positive outlook for the market across the globe.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global pharmaceutical fine chemicals market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, product, size and application.

Breakup by Type:

  • Proprietary
  • Non-proprietary

Breakup by Product:

  • Active Ingredients
  • Basic Building Blocks
  • Advanced Intermediates

Breakup by Size:

  • Big Molecules
  • Small Molecules

Breakup by Application:

  • Cardiovascular
  • Neurological
  • Oncological
  • Respiratory
  • Gastrointestinal
  • Musculoskeletal
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being BASF SE, Borregaard ASA, CHEMADA Industries Ltd. (Turpaz), Denisco Chemicals Pvt Ltd, Dupont De Nemours Inc., Eastman Chemical Company, Evonik Industries AG, Koninklijke DSM N.V., Lonza Group AG, Solvay S.A., Syntor Fine Chemicals Ltd. (Aceto Corporation) and W. R. Grace and Co. (Standard Industries Inc.).

Key Questions Answered in This Report:

  • How has the global pharmaceutical fine chemicals market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global pharmaceutical fine chemicals market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the size?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global pharmaceutical fine chemicals market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global Pharmaceutical Fine Chemicals Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Type

  • 6.1  Proprietary
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2  Non-proprietary
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7   Market Breakup by Product

  • 7.1  Active Ingredients
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2  Basic Building Blocks
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3  Advanced Intermediates
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8   Market Breakup by Size

  • 8.1  Big Molecules
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2  Small Molecules
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9   Market Breakup by Application

  • 9.1  Cardiovascular
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2  Neurological
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3  Oncological
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4  Respiratory
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5  Gastrointestinal
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast
  • 9.6  Musculoskeletal
    • 9.6.1 Market Trends
    • 9.6.2 Market Forecast
  • 9.7  Others
    • 9.7.1 Market Trends
    • 9.7.2 Market Forecast

10  Market Breakup by Region

  • 10.1  North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2  Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3  Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4  Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5  Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11  SWOT Analysis

  • 11.1  Overview
  • 11.2  Strengths
  • 11.3  Weaknesses
  • 11.4  Opportunities
  • 11.5  Threats

12  Value Chain Analysis

13  Porters Five Forces Analysis

  • 13.1  Overview
  • 13.2  Bargaining Power of Buyers
  • 13.3  Bargaining Power of Suppliers
  • 13.4  Degree of Competition
  • 13.5  Threat of New Entrants
  • 13.6  Threat of Substitutes

14  Price Analysis

15  Competitive Landscape

  • 15.1  Market Structure
  • 15.2  Key Players
  • 15.3  Profiles of Key Players
    • 15.3.1  BASF SE
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2  Borregaard ASA
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
    • 15.3.3  CHEMADA Industries Ltd. (Turpaz)
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4  Denisco Chemicals Pvt Ltd
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5  Dupont De Nemours Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6  Eastman Chemical Company
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7  Evonik Industries AG
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8  Koninklijke DSM N.V.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9  Lonza Group AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10  Solvay S.A.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11  Syntor Fine Chemicals Ltd. (Aceto Corporation)
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12  W. R. Grace and Co. (Standard Industries Inc.)
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 SWOT Analysis

List of Figures

  • Figure 1: Global: Pharmaceutical Fine Chemicals Market: Major Drivers and Challenges
  • Figure 2: Global: Pharmaceutical Fine Chemicals Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Pharmaceutical Fine Chemicals Market: Breakup by Type (in %), 2022
  • Figure 5: Global: Pharmaceutical Fine Chemicals Market: Breakup by Product (in %), 2022
  • Figure 6: Global: Pharmaceutical Fine Chemicals Market: Breakup by Size (in %), 2022
  • Figure 7: Global: Pharmaceutical Fine Chemicals Market: Breakup by Application (in %), 2022
  • Figure 8: Global: Pharmaceutical Fine Chemicals Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Pharmaceutical Fine Chemicals (Proprietary) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Pharmaceutical Fine Chemicals (Proprietary) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Pharmaceutical Fine Chemicals (Non-proprietary) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Pharmaceutical Fine Chemicals (Non-proprietary) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Pharmaceutical Fine Chemicals (Active Ingredients) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Pharmaceutical Fine Chemicals (Active Ingredients) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Pharmaceutical Fine Chemicals (Basic Building Blocks) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Pharmaceutical Fine Chemicals (Basic Building Blocks) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Pharmaceutical Fine Chemicals (Advanced Intermediates) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Pharmaceutical Fine Chemicals (Advanced Intermediates) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Pharmaceutical Fine Chemicals (Big Molecules) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Pharmaceutical Fine Chemicals (Big Molecules) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Pharmaceutical Fine Chemicals (Small Molecules) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Pharmaceutical Fine Chemicals (Small Molecules) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Pharmaceutical Fine Chemicals (Cardiovascular) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Pharmaceutical Fine Chemicals (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Pharmaceutical Fine Chemicals (Neurological) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Pharmaceutical Fine Chemicals (Neurological) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Pharmaceutical Fine Chemicals (Oncological) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Pharmaceutical Fine Chemicals (Oncological) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Pharmaceutical Fine Chemicals (Respiratory) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Pharmaceutical Fine Chemicals (Respiratory) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Pharmaceutical Fine Chemicals (Gastrointestinal) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Pharmaceutical Fine Chemicals (Gastrointestinal) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Pharmaceutical Fine Chemicals (Musculoskeletal) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Pharmaceutical Fine Chemicals (Musculoskeletal) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Pharmaceutical Fine Chemicals (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Pharmaceutical Fine Chemicals (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: North America: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: North America: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: United States: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: United States: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Canada: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Canada: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Asia-Pacific: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Asia-Pacific: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: China: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: China: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Japan: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Japan: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: India: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: India: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: South Korea: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: South Korea: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Australia: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Australia: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Indonesia: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Indonesia: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Others: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Others: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Europe: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Europe: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Germany: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Germany: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: France: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: France: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: United Kingdom: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: United Kingdom: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Italy: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Italy: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Spain: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Spain: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Russia: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Russia: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Others: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Others: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Latin America: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Latin America: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Brazil: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Brazil: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Mexico: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Mexico: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Others: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Others: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Middle East and Africa: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Middle East and Africa: Pharmaceutical Fine Chemicals Market: Breakup by Country (in %), 2022
  • Figure 85: Middle East and Africa: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 86: Global: Pharmaceutical Fine Chemicals Industry: SWOT Analysis
  • Figure 87: Global: Pharmaceutical Fine Chemicals Industry: Value Chain Analysis
  • Figure 88: Global: Pharmaceutical Fine Chemicals Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pharmaceutical Fine Chemicals Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Pharmaceutical Fine Chemicals Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Pharmaceutical Fine Chemicals Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 4: Global: Pharmaceutical Fine Chemicals Market Forecast: Breakup by Size (in Million US$), 2023-2028
  • Table 5: Global: Pharmaceutical Fine Chemicals Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 6: Global: Pharmaceutical Fine Chemicals Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Pharmaceutical Fine Chemicals Market: Competitive Structure
  • Table 8: Global: Pharmaceutical Fine Chemicals Market: Key Players